Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Measuring salt levels in kidneys with sodium MRI in kidney disease

Uses sodium MRI to measure salt in kidneys of adults with kidney disease.

Plain-language title generated from the registry record
Registry title: Kidney Sodium Functional Imaging

Key facts

Where
London, CanadaSee the site

Where in Canada

  • Victoria Hospital, London Health Sciences CentreLondon, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Trial code
NCT05014178
Record updated
12 February 2025
Original description
The corticomedullary gradient is largely responsible for developing the gradients that are needed to concentrate urine (more solutes and less water). The ability of the kidneys to produce concentrated urine is a major determinant of the ability to survive the warm weather. When temperatures are high, we lose water through sweat, and so the kidneys retain water to maintain fluidity in the blood. The maintenance of a sodium (salt) gradient is required for urine concentration because increased medullary sodium concentration increases the reabsorption of water into the kidney, to be redistributed in the blood. The purpose of this study is to know if the corticomedullary gradient is altered in patients across a wide spectrum of kidney disease using sodium Magnetic Resonance Imaging (MRI), a machine that takes pictures and measures the salt content in the kidneys. 23Na kidney MRI, will provide functional MR of the kidney as a non-invasive tool to describe medullary function to improve management of chronic and kidney disease.Read full original descriptionShow less

Kidney Sodium Functional Imaging: Evaluation of Kidney Medullary Sodium Content Using 23Na MRI in Kidney Disease

The corticomedullary gradient is largely responsible for developing the gradients that are needed to concentrate urine (more solutes and less water). The ability of the kidneys to produce concentrated urine is a major determinant of the ability to survive the warm weather. When temperatures are high, we lose water through sweat, and so the kidneys retain water to maintain fluidity in the blood. The maintenance of a sodium (salt) gradient is required for urine concentration because increased medullary sodium concentration increases the reabsorption of water into the kidney, to be redistributed in the blood. The purpose of this study is to know if the corticomedullary gradient is altered in patients across a wide spectrum of kidney disease using sodium Magnetic Resonance Imaging (MRI), a machine that takes pictures and measures the salt content in the kidneys. 23Na kidney MRI, will provide functional MR of the kidney as a non-invasive tool to describe medullary function to improve management of chronic and kidney disease.

Inclusion: Age ≥ 18 years; For healthy controls: lack of kidney disease, heart failure, liver cirrhosis and peripheral edema; For CKD stage 1-5: Estimated GFR < 90 mL/min/1.73m²; For patients on maintenance hemodialysis or peritoneal dialysis: more than 3 months duration of therapy.

Exclusion: Contraindication to MRI; Inability to tolerate MRI due to patient size and/or known history of claustrophobia; Mechanically implanted, electrically, or magnetically activated device or any metal in their body which cannot be removed, including but not limited to pacemakers, neurostimulators, biostimulators, implanted insulin pumps, aneurysm clips, bioprosthesis, artificial limb, metallic fragment or foreign body, tattoos, shunt, surgical staples (including clips or metallic sutures and/or ear implants.); Pregnant, breastfeeding or intending pregnancy.

ClinicalTrials.gov NCT05014178